[{"NetIncomeLoss_1_Q2_USD":-85313000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":63535000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":113138000.0,"AssetsCurrent_0_Q2_USD":727168000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":305000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-7000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":2526000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":1010000.0,"Depreciation_2_Q2_USD":5737000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":209864000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-1561000.0,"InventoryFinishedGoods_0_Q2_USD":4440000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_2_Q2_USD":201000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":50464000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestAndOtherIncome_1_Q2_USD":644000.0,"InterestAndOtherIncome_2_Q2_USD":3810000.0,"DueFromRelatedPartiesCurrent_0_Q2_USD":0.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":31586000.0,"MoneyMarketFundsAtCarryingValue_0_Q2_USD":230561000.0,"ContractWithCustomerLiability_0_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9000000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":16510000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ContractualObligation_0_Q2_USD":26200000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1377000.0,"ShareBasedCompensation_2_Q2_USD":34560000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-2744000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-814000.0,"Assets_0_Q2_USD":807683000.0,"CommonStockSharesIssued_0_Q2_shares":90228000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":7047000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-1129000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":520000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":3268000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":663000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":216000.0,"FinanceLeaseInterestExpense_1_Q2_USD":534000.0,"FinanceLeaseInterestExpense_2_Q2_USD":1049000.0,"AvailableForSaleSecurities_0_Q2_USD":256546000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":9200000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":13680000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":1373000.0,"OtherSundryLiabilitiesNoncurrent_0_Q2_USD":1787000.0,"Supplies_0_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":902000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":169000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-25000.0,"AccountsReceivableNetCurrent_0_Q2_USD":26519000.0,"PrepaidExpenseCurrent_0_Q2_USD":4429000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":88835000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":89451000.0,"MinorityInterest_0_Q2_USD":19271000.0,"ProceedsFromSaleOfAvailableForSaleSecurities_2_Q2_USD":10606000.0,"EarningsPerShareBasic_1_Q2_USD":-0.95,"EarningsPerShareBasic_2_Q2_USD":-1.84,"InventoryRawMaterials_0_Q2_USD":327000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1431000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":61414000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":116315000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":463000.0,"ShortTermInvestments_0_Q2_USD":256317000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":255242000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":3459000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-1129000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":520000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":63956000.0,"FinanceLeaseLiability_0_Q2_USD":43865000.0,"Liabilities_0_Q2_USD":392540000.0,"Cash_0_Q2_USD":198708000.0,"TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax_0_Q2_USD":1300000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":201900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":572000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":429269000.0,"OtherAssetsNoncurrent_0_Q2_USD":6862000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1060000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-88057000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-164475000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":50464000.0,"IncreaseDecreaseInInventories_2_Q2_USD":2016000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"OtherAssetsCurrent_0_Q2_USD":2052000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":47133000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"PaymentsToAcquireBusinessesGross_2_Q2_USD":1419000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":58000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":0.0,"InterestExpense_2_Q2_USD":1284000.0,"AccountsPayableCurrent_0_Q2_USD":5015000.0,"LiabilitiesCurrent_0_Q2_USD":77571000.0,"GainLossOnDispositionOfAssets_2_Q2_USD":0.0,"InventoryWorkInProcess_0_Q2_USD":3815000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":89451000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":88835000.0,"OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities_1_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":90179000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-1615000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-1334000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":17644000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":34560000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":6858000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_2_Q2_USD":-138000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-85144000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-163686000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0439,"InterestExpense_1_Q2_USD":651000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":104225000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6481000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":7709000.0,"NetIncomeLoss_2_Q2_USD":-163661000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":36984000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":433000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":415143000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":429269000.0,"AdditionalPaidInCapital_0_Q2_USD":1344912000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":12523000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":0.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-4025000.0,"SubleaseIncome_1_Q2_USD":306000.0,"SubleaseIncome_2_Q2_USD":598000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0473,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":2653000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":5247000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":13883000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-499000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"EarningsPerShareDiluted_1_Q2_USD":-0.95,"EarningsPerShareDiluted_2_Q2_USD":-1.84,"AllocatedShareBasedCompensationExpense_1_Q2_USD":17644000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":34560000.0,"PreferredStockSharesAuthorized_0_Q2_shares":125000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":14266000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":807683000.0,"OperatingLeaseCost_1_Q2_USD":255000.0,"OperatingLeaseCost_2_Q2_USD":564000.0,"PreferredStockValue_0_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":9813000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1304000.0,"AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments_2_Q2_USD":-258000.0,"InventoryNet_0_Q2_USD":8582000.0,"OperatingIncomeLoss_1_Q2_USD":-85137000.0,"OperatingIncomeLoss_2_Q2_USD":-166212000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":42888000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":67288000.0,"CommonStockSharesAuthorized_0_Q2_shares":225000000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-126874000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":34368000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":141209000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":801000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":144000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q2_USD":8653000.0,"CommonStockSharesOutstanding_0_Q2_shares":90228000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-1903000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":303003000.0,"LeaseCost_1_Q2_USD":3136000.0,"LeaseCost_2_Q2_USD":6262000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-948381000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":12090000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":22000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":48117000.0,"LongTermInvestments_0_Q2_USD":229000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":138242000.0,"StockholdersEquity_0_Q2_USD":395872000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":12279000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":127242000.0,"ProfitLoss_2_Q2_USD":-163661000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":5000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-33501000.0,"OperatingExpenses_1_Q2_USD":128025000.0,"OperatingExpenses_2_Q2_USD":233500000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1185000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":5653000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20200630","fy":"2019.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]